These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 18622676

  • 1. Pharmacokinetic-pharmacodynamic target attainment analysis of cefozopran in Japanese adult patients.
    Ikawa K, Nomura K, Morikawa N, Ikeda K, Ohge H, Sueda T, Taniwaki M.
    J Infect Chemother; 2008 Apr; 14(2):130-6. PubMed ID: 18622676
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetic–pharmacodynamic target attainment analysis of meropenem in Japanese adult patients.
    Ikawa K, Morikawa N, Ohge H, Ikeda K, Sueda T, Taniwaki M, Kurisu K.
    J Infect Chemother; 2010 Feb; 16(1):25-32. PubMed ID: 20082106
    [Abstract] [Full Text] [Related]

  • 3. Optimized dosage and frequency of cefozopran for patients with febrile neutropenia based on population pharmacokinetic and pharmacodynamic analysis.
    Nomura K, Morikawa N, Ikawa K, Ikeda K, Fujimoto Y, Shimizu D, Taniguchi K, Shimura K, Kanbayashi Y, Komori T, Matsumoto Y, Fujita N, Shimazaki C, Taniwaki M.
    J Antimicrob Chemother; 2008 Apr; 61(4):892-900. PubMed ID: 18276604
    [Abstract] [Full Text] [Related]

  • 4. Population pharmacokinetic modeling and pharmacodynamic assessment of cefozopran in pediatric patients.
    Ikawa K, Kozumi T, Ikeda K, Morikawa N, Kobayashi R.
    Jpn J Antibiot; 2009 Oct; 62(5):435-44. PubMed ID: 20055120
    [Abstract] [Full Text] [Related]

  • 5. Population pharmacokinetics and pharmacodynamics of meropenem in Japanese pediatric patients.
    Ikawa K, Morikawa N, Ikeda K, Miki M, Kobayashi M.
    J Infect Chemother; 2010 Apr; 16(2):139-43. PubMed ID: 20094749
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic-pharmacodynamic target attainment analysis of doripenem in infected patients.
    Ikawa K, Morikawa N, Uehara S, Monden K, Yamada Y, Honda N, Kumon H.
    Int J Antimicrob Agents; 2009 Mar; 33(3):276-9. PubMed ID: 19095418
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetic-pharmacodynamic target attainment analysis of biapenem in adult patients: a dosing strategy.
    Ikawa K, Morikawa N, Ikeda K, Ohge H, Sueda T, Suyama H, Doi M, Kuwabara M.
    Chemotherapy; 2008 Mar; 54(5):386-94. PubMed ID: 18769027
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units.
    Roos JF, Bulitta J, Lipman J, Kirkpatrick CM.
    J Antimicrob Chemother; 2006 Nov; 58(5):987-93. PubMed ID: 16943209
    [Abstract] [Full Text] [Related]

  • 9. Population Pharmacokinetic Analysis of Doripenem after Intravenous Infusion in Korean Patients with Acute Infections.
    Lee DH, Kim YK, Jin K, Kang MJ, Joo YD, Kim YW, Moon YS, Shin JG, Kiem S.
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223378
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Using Population Pharmacokinetic Modeling and Monte Carlo Simulations To Determine whether Standard Doses of Piperacillin in Piperacillin-Tazobactam Regimens Are Adequate for the Management of Febrile Neutropenia.
    Sime FB, Hahn U, Warner MS, Tiong IS, Roberts MS, Lipman J, Peake SL, Roberts JA.
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807922
    [Abstract] [Full Text] [Related]

  • 16. Pharmacodynamic evaluation of biapenem in peritoneal fluid using population pharmacokinetic modelling and Monte Carlo simulation.
    Ikawa K, Morikawa N, Ikeda K, Ohge H, Sueda T.
    Int J Antimicrob Agents; 2008 Oct; 32(4):339-43. PubMed ID: 18602798
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.